Navigation Links
Oramed Pharmaceuticals Chosen to Present Oral Insulin Trial Results at EASD Conference (September 7-11, Rome)
Date:8/18/2008

JERUSALEM, Israel, August 18 /PRNewswire-FirstCall/ -- Oramed Pharmaceuticals, Inc. (OTCBB: ORMP.OB) (http://www.oramed.com), a developer of oral delivery systems, announced today that its abstract, entitled "Open Label Study to Assess the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Five Oral Insulin Formulations in Healthy Subjects," has been chosen for presentation at the upcoming 44th Annual Meeting of the European Association for the Study of Diabetes (EASD) in Rome, highlighting the successful results from its oral insulin trials on healthy volunteers.

Oramed's poster has been assigned presentation number PS 093 New Treatments and is available for viewing throughout the conference. Oramed's Chief Scientific Officer, Dr. Miriam Kidron, and Dr. Ehud Arbit, Oramed's Director of Research and Development, will present the poster on Tuesday Sept. 9, 2008, from 12:30 p.m. to 1:30 p.m.

"The fact that Oramed has been selected to present research at the EASD Conference underscores the importance of our work developing an oral insulin capsule," said Nadav Kidron, Oramed CEO. "We look forward to sharing the results of our Phase 1B trials with top diabetes researchers from around the world."

For more information about the EASD and the upcoming conference, please visit http://www.easd.org.

About Oramed Pharmaceuticals

Oramed Pharmaceuticals is a technology pioneer in the field of oral delivery solutions for drugs and vaccines presently delivered via injection. Oramed is seeking to revolutionize the treatment of diabetes through its patented flagship product, an orally ingestible insulin capsule currently in phase 2 clinical trials. Established in 2006, Oramed's technology is based on over 25 years of research by top research scientists at Jerusalem's Hadassah Medical Center. The Company's corporate and R&D headquarters are
'/>"/>

SOURCE Oramed Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Oramed Pharmaceuticals Announces Successful Phase 2A Clinical Trial of its Oral Insulin Capsule
2. Oramed Pharmaceuticals to Hold Conference Call on August 6 to Present Results of Phase 2A Oral Insulin Capsule Clinical Trials
3. Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
4. Rib-X Pharmaceuticals, Inc. Announces Recent and Upcoming Presentations at Scientific Conferences
5. Quark Pharmaceuticals Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in Diabetic Macular Edema
6. Idenix Pharmaceuticals Advances HCV Discovery Program to Clinic
7. Celator Pharmaceuticals Raises Series C Financing in Excess of $22.5 Million
8. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results and Provide a Clinical Program Update on August 7, 2008
9. Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer
10. Meditrina Pharmaceuticals, Inc. Opens Investigational New Drug (IND) Application for Phase IIb Clinical Trial With MPI-676 in Endometriosis
11. BioNumerik Pharmaceuticals Observes Evidence of a Survival Increase in Lung Cancer Patients Participating in Tavocept(TM) Clinical Trial

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)..., NEW YORK, Nov. 25 Reportlinker...s available in its catalogue: ,, Mammography ...ttp://www.reportlinker.com/p0164330/Mammography-Eq...Rising incidence of breast cancer in industrialize...tor influencing growth in the mammography market. ...
(Date:11/25/2009)..., WALTHAM, Mass., Nov. 25 Accord... authority on medical technology market intelligen...ation devices will continue to see rapid growth ov... slowdown. MRG,s US Markets for Trauma Devices ...ghly dynamic over the next five years, with compet...
(Date:11/25/2009)..., NEW YORK, Nov. 25 Reportlinker...s available in its catalogue: ,, Pain Managem...er.com/p0164220/Pain-Management---Global-Trends.ht..., emergence of pain management clinics, and the ad...wth in the pain management market. Healthcare refo...
Breaking Medicine Technology:Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7Reportlinker Adds Mammography Equipment - A Global Market Perspective 8US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5Reportlinker Adds Pain Management - Global Trends 6Protecting the food crops of the future 8870 1Protecting the food crops of the future 8870 2Discovery of the cells water gate may lead to new cancer drugs 8868 1Discovery of the cells water gate may lead to new cancer drugs 8868 2Quest Diagnostics Announces Final Tender Offer Results 12672 1Quest Diagnostics Announces Final Tender Offer Results 12672 2Quest Diagnostics Announces Final Tender Offer Results 12672 3
(Date:11/27/2009)... , ROCHESTER, N.Y., Nov. 27 /PRNewswire-USNewsw...alth care provider and fortunately every year, new...vention. But do all vaccines boost immunity for th...ional ,booster shots, needed to keep immunity stro...he Journal of the American Academy of Pediatrics, ...
(Date:11/27/2009)..., KIBBUTZ SHAMIR, Israel, Nov. 27 /PRNewswire-F... SHMR ) ( "Shamir" ), a leading provider of innov...ns market, announced today that its board of direc...gregate amount of US$ 10 million (approximately NI...resentative rate of exchange), or approximately US...
(Date:11/27/2009)...g and cycling plus low-emission vehicles may reduc... , FRIDAY, Nov. 27 (HealthDay News) -- Encouragi...ing cars would offer much greater public health be...s, U.K. researchers have found. , The study com...rnative urban land transport scenarios for London,...
(Date:11/27/2009)... , SEATTLE, Nov. 27 /PRNewswire... received record-high Thanksgiving traffic numbers...re Thanksgiving, providing a clear picture of what...r. The average Thanksgiving meal in 2009 weighed i...ase from last year,s feast. According to the Allre...
(Date:11/27/2009)... Multi-purpose bilingual colori...ned for use by the business community to educate -... subjects from Safety issues to Dinosuars to ABC,S... Saint Louis, MO (PRWEB) November 27, 2009 --...ronics or toys to keep them busy any hour of the d...
Breaking Medicine News(10 mins):Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 4Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2
...rticularly sensitive to cancer-causing pollutants ...regnant women and their newborn babies // .Past st... more harmful to fetuses than their mothers, despi... samples from 265 mothers and their newborn babies...
... in the United States suffer from erectile dysfunc...r men. With exercise and weight loss // , obese me... their sexual function say researchers. Researc...ile function.The study was conducted from October ...
...at estrogen therapy does not decrease, but may inc...en, say researchers //.Previous studies have repor... use and lower risk of dementia. A placebo-cont...esearchers found 47 participants were diagnosed wi...
...ess stress in your 20s could reduce the risk of de...dults who react to // psychological stress with sp...h blood pressure when they are in their 40s. Sp...e. In a large study more than 4,000 participants c...
...gs may be able to anticipate seizures in children ...om the dogs in this study was // licking, often o...whimpering, and “protective" behavior without aggr...alerting canines include Golden Retriever, Standar...
...d patients consume about 40 milligrams of vitamin ...nts of // vitamin C may protect against rheumatoid...women between the ages of 45 and 74. Participants'...t one month and participants who did not consume l...
Other Medicine News:
...doscopic CycloPhotocoagulation (ECP) is a surgical...t, endoscopy and visualized laser application. The...iewed by the surgeon, from the anterior or posteri...e target tissues are easily and accurately identif...
...doscopic CycloPhotocoagulation (ECP) is a surgical...t, endoscopy and visualized laser application. The...iewed by the surgeon, from the anterior or posteri...e target tissues are easily and accurately identif...
...doscopic CycloPhotocoagulation (ECP) is a surgical...t, endoscopy and visualized laser application. The...iewed by the surgeon, from the anterior or posteri...e target tissues are easily and accurately identif...
...doscopic CycloPhotocoagulation (ECP) is a surgical...t, endoscopy and visualized laser application. The...iewed by the surgeon, from the anterior or posteri...e target tissues are easily and accurately identif...
Medicine Products: